Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Recruiting2

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 13 (75.0%)

Phase 31 (25.0%)

Trials by Status

recruiting250%

completed250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NCT07174336

recruitingphase_1

A Study of [14C]-LY4064809 in Healthy Participants

NCT07519525

completedphase_1

A Study of LY4064809 in Healthy Adult Chinese Participants

NCT07247357

completedphase_1

A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

NCT06991179

Clinical Trials (4)

Showing 4 of 4 trials

NCT07174336Phase 3

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Recruiting

NCT07519525Phase 1

A Study of [14C]-LY4064809 in Healthy Participants

Recruiting

NCT07247357Phase 1

A Study of LY4064809 in Healthy Adult Chinese Participants

Completed

NCT06991179Phase 1

A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4